Development and Validation of a Bioanalytical Method for the Determination of Nimodipine Concentration in Plasma of Rats
DOI:
https://doi.org/10.31351/vol34iss1pp133-142Keywords:
bioanalytical method, HPLC, nimodipine, pre-clinical pharmacokinetics, validationAbstract
Nimodipine is a calcium channel blocker used for the prevention of cerebral vasospasm after subarachnoid hemorrhage, a type of strokes. Its unique ability to selectively dilate blood vessels in the brain makes it a crucial medication in neurology. Pharmaceutical analysis of nimodipine is important to ensure its safety, efficacy, and quality, and to establish optimal dosage regimens for patients. Hence, a bioanalytical method based on high performance liquid chromatography (HPLC) was developed and validated to determine the concentration of nimodipine in rat’s plasma that has been spiked with the drug. The current method development included the processing of plasma followed by injection into HPLC system with ultraviolet detector. Sample preparation involved utilizing 1-pentanol as an extraction solvent. Chromatographic separation was performed on octadecylsilane (ODS) column using water/methanol as mobile phase. Nifedipine was used as an internal standard (IS). The validation results indicated that the proposed method is specific and linear for nimodipine within the concentration range of 10.0 to 150.0 ng/mL. The accuracy and precision of the method were assessed for both inter-day and intra-day measurements. The results revealed accuracies ranging from 97.00% to 99.66% and 95.12% to 101.28%, respectively. In terms of precision, the values ranged from 1.17% to 3.10% for inter-day measurement and 1.00% to 2.23%, for intra-day measurements. The recovery rates for nimodipine and nifedipine were 95.91% and 86.61%, respectively. Furthermore, the method demonstrated good stability at short-term room temperature (99.44%), long-term freeze temperature (97.80%), and freeze/thaw (97.04%) conditions. Overall, these findings suggest that the method is suitable for use in pre-clinical pharmacokinetic studies involving involving nimodipine-containing drug delivery system.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Shah VP. The history of bioanalytical method validation and regulation: evolution of a guidance document on bioanalytical methods Validation. AAPS J. 2007;9: E43–E47.
Thompson M., Ellison SL. R., Wood R., Harmonised guidelines for single laboratory validation of method of analysis. Pure Appl. Chem. 2002;74:835-855.
Salih OS., Al-Akkam EJ. Pharmacokinetic parameters of ondansetron in rats after oral solution and transdermal invasomes gel: A comparison study. J. Adv. Pharm. Edu. Res. 2023;13(1):116–121.
Al-Tamimi DJ., Al-Kinani KK., Taher SS., Hussein AA. Effect of food on the pharmacokinetics of fluoxetine in healthy male adult volunteers. Iraqi J. Pharm. Sci. 2022; 31, Suppl.:153–161.
Rocci ML., Devanarayan V., Haughey DB., Jardieu P., Confirmatory reanalysis of incurred bianalytical samples, AAPS Journal. 2007;9:E336–E343.
Al-Tamimi JJ., Bioequivalence and pharmacokinetics of two formulations of amlodipine tablets in healthy subjects. Iraqi J. Pharm. Sci. 2014;23(1):60–67.
Deshpande M., Kasture VS., Mohan M., Chaudhari S. Practical approach for development and validation of bioanalytical method: A review. SnKasture, Mahalaxmi Mohan et al. Practical Approach. Inventi Impact: Pharm Analysis and Quality Assurance. 2017;1:1-8.
Alhamd AK. Bioequivalence of two formulations of amoxicillin in human healthy volunteers on (HPLC) technique. Iraqi J. Pharm. Sci. 2010;19 (1):14–20.
Swartz M. HPLC detectors: A brief review. J. Liquid Chromatography & Related Technologies. 2010;33: 1130–1150.
Sunil A., Anju G., Rajat V. HPLC detectors, their types and use: A review. Organic & Medicinal Chemistry International J. 2018;6:555700.
Rha C-S, Choi Y-M, Kim J-C, Kim D-O. Cost-effective simultaneous separation and quantification of phenolics in green and processed tea using HPLC–UV–ESI single-quadrupole MS detector and Python Script. Separations. 2021;8(4):45.
Mahdi MB., Aliasghar A., Kadhim B. Sixty-four multi-slice cerebral CT angiographic findings in early non-traumatic subarachnoid hemorrhage. J. Fac. Med. Baghdad, 2014;56(2):151 –156.
Meyer H., Wehinger E., Bossert F., Scherling D. Nimodipine: Synthesis and metabolic pathway. Arzneimittelforschung, 1983;33:106–112.
Winkler SR. Stroke,. In: Chisholm-Burns MA., Schwinghammer TL., Wells BG., Malone PM., Kolesar JM., DiPiro. JT. Pharmacotherapy Principles & Practice, 11th ed. McGraw-Hill Education, New York;2016. pp. 193–205.
Dorhout Mees SM., Rinkel GJ., Feigin VL., Algra A., van den Bergh WM., Vermeulen M., van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;2007(3):CD0002773.
Herbette LG., Mason PE., Sweeney KR., Trumbore MW., Mason RP. Favorable amphiphilicity of nimodipine facilitates its interactions with brain membranes. Neuropharmacology. 1994;33:241–249.
Moffat AC., Osselton MD., Widdop B. Clarke’s Analysis of Drugs and Poisons, 4th ed. The Pharmaceutical Press, London;2011. pp. 1781–1782.
Alhagiesa AW., Ghareeb MM. Formulation and characterization of nimodipine nanoparticles for the enhancement of solubility and dissolution rate. Iraqi J. Pharm. Sci. 2021;30(2):143–152.
Baranda AB., Etxebarria N., Jimenez RM., Alonso RM. Development of a liquid–liquid extraction procedure for five 1,4-dihydropyridines calcium channel antagonists from human plasma using experimental design. Talanta. 2005;67: 933–941.
Do Nascimento DF., De Moraes ME. Determination of nimodipine in plasma by HPLC-MS/MS and pharmacokinetic application. Brazilian J. Pharm. Sci. 2010;46:665-677.
Sotoudegan F. Development of an RP-HPLC-UV method for simultaneous detection of nimodipine and its metabolite in cerebrospinal fluid of rat. Iranian J. Pharm. Res. 2017;16:471–477.
Bioanalytical method validation and study sample analysis M10. International council for harmonization of technical requirements for pharmaceuticals for Human 2022. https://database.ich.org/sites/default/files/M10. Accessed 26 June 2023.
Wieling J. LC-MS-MS Experiences with internal standards. Chromatographia. 2002; 55:S107–S113.
Moosavi SM., Ghassabian S. Linearity of calibration curves: A review of criteria for assessment of method reliability. In: M. Staffer, editor. Calibration and validation of analytical methods - A sampling of current approaches, Intechopen; 2018. pp. 109–127.
Al-Akkam EJ, Rasool AA, Badwan AA, Qinna N. Development and validation of a sensitive and accurate method for determination of atorvastatin and rosuvastatin in rat plasma by reversed-phase high performance liquid chromatography with UV detection. Int J Pharm Pharm Sci. 2013;5:211-219.
Epshtein NA. Validation of analytical procedures: graphic and calculated criteria for assessment of methods linearity in practice. Drug development and registration. 2019;8:122–130.
Al-Shammari WT H., Al-Ogaidi AJ. M. Determination of active ingredient in tamsulosin drug by using HPLC. Iraqi J. Agricultural Sci. 2022;53(3):561–569.
Armbruster DA., Pry T. Limit of blank, limit of detection and limit of quantitation. Clin. Biochem. Rev. 2008;29(suppl 1):S49–S52.
Belouafa S., et. al., Statistical tools and approaches to validate analytical methods: Methodology and practical examples. Int. J. Metrol. Qual. Eng. 2017; 8:1–10.
Boudreau SP., McElvain JS., Martin LD., Dowling T., Fields SM. Method validation by phase of development: An acceptable analytical practice. Pharm. Tech. 2004;28:54–66.
Yaseen A., Ghareeb MM., Alsaffar DF. Ming TS., Gazzali AM. Development and validation of HPLC method for the detection of fusidic acid loaded in non-ionic and cationic nanoemulsion-based gels. Biomed. and Pharmacol J. 2023;16(1):573–580.
Betz JM., Brown PN., Romanc MC., Accuracy, precision, and reliability of chemical measurements in natural products research. Fitoterapia. 2011;82(1):44–52.
Shuai Yu, Wenguo Xing, Fumin Xue, Cheng Yan., Bing Li. Solubility and thermodynamic properties of nimodipine in pure and binary solvents at a series of temperatures. J. Chem. Thermodynamics. 2021;152:106259.
Taleuzzaman M., Gilani SJ., Ali S., Hafeez A., Nagarajan K. Bio-analytical method validation. Austin J. Ana. Pharm. Chem. 2015;(2):)1–5.
Tiwari G., Tiwari R. Bioanalytical method validation: An updated review. Pharm. Methods. 2010;(1):25–38.
Galvao AF., Ajimura TO., Aguiar FA., Borgesb KB., de Gaitani CM. Stability-indicating methods for the enantioselective determination of dihydropyridines by high performance liquid chromatography and capillary electrophoresis. Anal. Methods. 2012;4:2953–2961.
De Luca M., Ioele G., Ragno G. 1,4-Dihydropyridine antihypertensive drugs: Recent advances in photo-stabilization strategies. Pharmaceutics. 2019;11(85):1–13.
Marciniec B, Ogrodowczyk M. Thermal stability of 1,4-dihydropyridine derivatives in solid state. Acta Pol Pharm. 2006;63(6):477-484.
Panda SS., Kumar VV., S. Mahapatra S. Stability -indicating LC method for estimation of nimodipine in dosage form and spiked serum using systematized design of experiments (DoE) approach. Analytical Chemistry Letters. 2020;10:4:459-476.
Briscoe CJ., Hage DS. Factors affecting the stability of drugs and drug metabolites in biological matrices. Bioanalysis. 2009;1(1):205–220.
Sonawane LV., Poul BN., Usnale SV., Waghmare PV., Surwase LH. Bioanalytical method validation and its pharmaceutical application- A review. Pharm. Anal. Acta. 2014;5(3):1–7.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
